AbbVie 2012 Annual Report Download - page 113

Download and view the complete annual report

Please find page 113 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

13NOV201221365766
PROXY STATEMENT
Table of Contents
Solicitation of Proxies ........................................................ 1
Information about the Annual Meeting ............................................ 1
Who Can Vote ............................................................ 1
Notice and Access .......................................................... 1
Voting by Proxy ............................................................ 1
Revoking a Proxy .......................................................... 1
Discretionary Voting Authority .................................................. 1
Quorum and Vote Required to Approve Each Item on the Proxy .......................... 2
Effect of Broker Non-Votes and Abstentions ........................................ 2
Inspectors of Election ....................................................... 2
Cost of Soliciting Proxies ..................................................... 2
AbbVie Savings Plan ........................................................ 3
Separation of AbbVie from Abbott Laboratories ..................................... 3
Corporate Governance Materials ................................................ 3
Information Concerning Director Nominees (Item 1 on Proxy Card) ...................... 4
The Board of Directors and its Committees ........................................ 9
Communicating with the Board of Directors ........................................ 11
Director Compensation ....................................................... 12
Ownership of Securities ....................................................... 14
Executive Compensation ...................................................... 16
Compensation Discussion and Analysis ........................................... 16
Compensation Committee Report ............................................... 28
Summary Compensation Table ................................................. 29
2012 Grants of Plan-Based Awards .............................................. 32
2012 Outstanding Equity Awards at Fiscal Year-End .................................. 35
2012 Option Exercises and Stock Vested .......................................... 38
Pension Benefits ........................................................... 38
2012 Nonqualified Deferred Compensation ........................................ 42
Potential Payments Upon Termination or Change in Control ............................ 42
Ratification of Ernst & Young LLP as Auditors (Item 2 on Proxy Card) .................... 45
Audit Information ........................................................... 45
Report of the Audit Committee ................................................. 48
Say on Pay—An Advisory Vote on the Approval of Executive Compensation (Item 3 on Proxy Card) 48
Say When on Pay—An Advisory Vote on the Frequency of Future Approvals of Executive
Compensation (Item 4 on Proxy Card) .......................................... 49
Approval of the AbbVie 2013 Incentive Stock Program (Item 5 on Proxy Card) .............. 49
Procedures for Approval of Related Person Transactions ............................... 55
Transactions with Abbott ...................................................... 55
Section 16(a) Beneficial Ownership Reporting Compliance ............................. 65
Other Matters .............................................................. 65
i